Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Xiao-Dong Zhang · SciRah

Researcher profile · Semantic Scholar

Xiao-Dong Zhang

Share profile

Xiao-Dong Zhang — researcher profile on SciRah

h-index: 20
Works: 79
Citations: 2,003

Most-cited papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.
Huiyan Luo, Jin Lu, Yuxian Bai, T. Mao +26 more
2021Journal of the American Medical Association (JAMA)718 citations Open access
Semantic Scholar
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions
B. Wong, Lian Zhang, Jun-ling Ma, Kai-Feng Pan +10 more
2011Gut164 citations
Semantic Scholar
Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial.
Jian-Xing He, C. Su, W. Liang, Shi-Dong Xu +29 more
2021The Lancet Respiratory Medicine149 citations
Semantic Scholar
miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells.
Yixuan Liu, R. Xing, Xiao-Dong Zhang, Weiwei Dong +5 more
2013DNA Repair85 citations
Semantic Scholar
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.
Yuan-Kai Shi, Xing-Sheng Hu, Shu-Cai Zhang, D. Lv +17 more
2021The Lancet Respiratory Medicine83 citations
Semantic Scholar
Safety, Clinical Activity and Pharmacokinetics of Alflutinib (AST2818) in Advanced NSCLC Patients with EGFR T790M Mutation.
Yuan-Kai Shi, Shu-Cai Zhang, Xing-Sheng Hu, Ji-Feng Feng +15 more
2020Journal of Thoracic Oncology80 citations Open access
Semantic Scholar
A Phase II Trial of Paclitaxel and Cisplatin in Patients With Advanced Squamous-Cell Carcinoma of the Esophagus
Xiao-Dong Zhang, Lin Shen, Jie Li, Yan Li +2 more
2008American Journal of Clinical Oncology54 citations
Semantic Scholar
Nimotuzumab plus paclitaxel and cisplatin as the first line treatment for advanced esophageal squamous cell cancer: A single centre prospective phase II trial
Ming Lu, Xi-Cheng Wang, Lin Shen, J. Jia +8 more
2016Cancer Science49 citations Open access
Semantic Scholar
Upregulation of circ_001569 predicts poor prognosis and promotes cell proliferation in non-small cell lung cancer by regulating the Wnt/β-catenin pathway.
L. Ding, Wei-Dong Yao, Junguo Lu, Jun Gong +1 more
2018Oncology Letters48 citations Open access
Semantic Scholar
Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways
J. Jia, T. Martin, L. Ye, L. Meng +3 more
2017International Journal of Molecular Medicine45 citations Open access
Semantic Scholar
Programmed death‐ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor
Wen-Cheng Zhang, Q. Pang, Xiao-Dong Zhang, Ci-Hui Yan +8 more
2017Cancer Science44 citations Open access
Semantic Scholar
Detection of gastric carcinoma‐associated MG7‐Ag by serum immuno‐PCR assay in a high‐risk Chinese population, with implication for screening
Lian Zhang, Jun Ren, Kai-Feng Pan, Jun-ling Ma +7 more
2010International Journal of Cancer43 citations Open access
Semantic Scholar
Efficacy and Safety of Niraparib as Maintenance Treatment in Patients with Extensive-Stage Small Cell Lung Cancer after First-Line Chemotherapy: A Randomized, Double-Blind, Phase 3 Study.
X. Ai, Yue-Yin Pan, Jian-Hua Shi, N. Yang +33 more
2021Journal of Thoracic Oncology40 citations Open access
Semantic Scholar
Development and Validation of an Individualized Nomogram for Predicting Survival in Patients with Esophageal Carcinoma after Resection
F. Du, Zhi-Wei Sun, J. Jia, Ying Yang +5 more
2020Journal of Cancer39 citations Open access
Semantic Scholar
ESCORT-1st: A randomized, double-blind, placebo-controlled, phase 3 trial of camrelizumab plus chemotherapy versus chemotherapy in patients with untreated advanced or metastatic esophageal squamous cell carcinoma (ESCC).
Rui-Hua Xu, Huiyan Luo, Jin Lu, Yuxian Bai +16 more
2021Journal of Clinical Oncology33 citations
Semantic Scholar
Livin, Survivin and Caspase 3 as early recurrence markers in non-muscle-invasive bladder cancer
Jian-Wen Wang, Xiao-Dong Zhang, P. Wei, Jun-Hui Zhang +5 more
2014World journal of urology32 citations
Semantic Scholar
Anlotinib combined with gefitinib can significantly improve the proliferation of epidermal growth factor receptor-mutant advanced non-small cell lung cancer in vitro and in vivo
Tao Li, Yu-Xuan Qian, Chen-Fei Zhang, J. Uchino +5 more
2021Translational Lung Cancer Research27 citations Open access
Semantic Scholar
Long noncoding RNA LINC00337 accelerates the non-small-cell lung cancer progression through inhibiting TIMP2 by recruiting DNMT1.
Xiao-Dong Zhang, Jun Gong, Junguo Lu, Jia Chen +3 more
2019American journal of translational research24 citations
Semantic Scholar
Promotion of Cellular Growth and Motility Is Independent of Enzymatic Activity of Fibroblast Activation Protein-α.
Baobei Lv, Fei Xie, Peng-Xiang Zhao, Xue-Mei Ma +4 more
2016Cancer Genomics & Proteomics24 citations
Semantic Scholar
The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma
J. Jia, Yong Cui, Ming Lu, Xiao-Li Wang +12 more
2016Clinical and Translational Oncology21 citations
Semantic Scholar
Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention.
Guo-shuang Feng, Jun-ling Ma, B. Wong, Lian Zhang +9 more
2008World Journal of Gastroenterology17 citations Open access
Semantic Scholar
Characterization of Phenotypic and Genotypic Traits of Klebsiella pneumoniae from Lung Cancer Patients with Respiratory Infection
L. Ding, Zhiqiang Yang, Junguo Lu, Li-Chao Ma +5 more
2020Infection and Drug Resistance16 citations Open access
Semantic Scholar
Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study.
Xiao-Dong Zhang, Y. Shu, Jun Liang, Feng-Chun Zhang +8 more
2012Chinese journal of cancer research = Chung-kuo yen cheng yen chiu16 citations
Semantic Scholar
Nimotuzumab Plus Paclitaxel and Cisplatin as a 1st-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study
Xiao-Dong Zhang, J. Jia, Ming Lu, Xi-Cheng Wang +13 more
2019Journal of Cancer14 citations Open access
Semantic Scholar
A phase Ib/II study of AK112, a PD-1/VEGF bispecific antibody, as first- or second-line therapy for advanced non–small cell lung cancer (NSCLC).
Cai-Cun Zhou, S. Ren, Yongzhong Luo, Lei Wang +15 more
2022Journal of Clinical Oncology13 citations
Semantic Scholar
Orthotopic ileal neobladder reconstruction in patients with recurring bladder cancer after renal transplantation – a report of two cases and a review of the literature
Jian-Wen Wang, N. Xing, Xiao-Dong Zhang, Yong Yan +4 more
2009Clinical Transplantation12 citations
Semantic Scholar
Efficacy and safety of alflutinib (AST2818) in patients with T790M mutation-positive NSCLC: A phase IIb multicenter single-arm study.
Yuan-Kai Shi, Xing-Sheng Hu, Shu-Cai Zhang, D. Lv +16 more
202011 citations
Semantic Scholar
microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2
Xian-Peng Ma, Di Wu, Xiao-Dong Zhang, Xiao-Lei Shao +1 more
2020Technology in Cancer Research and Treatment9 citations Open access
Semantic Scholar
Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study
Xiao-Dong Zhang, Y. Shu, Jun Liang, Feng-Chun Zhang +8 more
20128 citations Open access
Semantic Scholar
Large cell neuroendocrine carcinoma transformation: A novel acquired drug resistance mechanism in colorectal adenocarcinoma
F. Du, Ying Han, Xiao Hu, Yanjie Xiao +7 more
2023Cancer Innovation7 citations Open access
Semantic Scholar
MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma
F. Du, D. Dong, Xiao-Dong Zhang, J. Jia
2021Technology in Cancer Research and Treatment7 citations Open access
Semantic Scholar
Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy
Zhi-Wei Sun, J. Jia, F. Du, Ying Yang +4 more
2019Translational Cancer Research7 citations Open access
Semantic Scholar
Central nervous system efficacy of furmonertinib versus gefitinib in patients with non–small cell lung cancer with epidermal growth factor receptor mutations: Results from FURLONG study.
Gong-Yan Chen, Xiang Wang, Yun-Peng Liu, Lin Wu +16 more
2022Journal of Clinical Oncology6 citations
Semantic Scholar
Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma.
Ying Yang, J. Jia, Zhi-Wei Sun, Chuan-Ling Liu +8 more
2021Future Oncology6 citations Open access
Semantic Scholar
Nimotuzumab plus paclitaxel and cisplatin as 1st line treatment for unresectable esophageal squamous cell carcinoma: Long term follow-up of survival in a phase II study.
Xiao-Dong Zhang, J. Jia, Ming Lu, Xi-Cheng Wang +10 more
20176 citations
Semantic Scholar
[Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Xiao-Dong Zhang, Lin Shen, Jie Li, Yan Li +3 more
2007Zhonghua zhong liu za zhi [Chinese journal of oncology]5 citations
Semantic Scholar
Microarray analysis of miRNA based on the regional lymph node metastasis status of esophageal squamous cell carcinoma
Ying Xu, Dianshui Sun, Xiao-Dong Zhang, Jie Liu +4 more
2021Translational Cancer Research4 citations Open access
Semantic Scholar
Plasma thymidylate synthase and dihydrofolate reductase mRNA levels as potential predictive biomarkers of pemetrexed sensitivity in patients with advanced non-small cell lung cancer
Tao Li, Jinbo Huang, Junguo Lu, Rong Li +4 more
2020Journal of Thoracic Disease4 citations Open access
Semantic Scholar
Prognosis impact of clinical characteristics in patients with inoperable esophageal squamous cell carcinoma
Ying Yang, J. Jia, Zhi-Wei Sun, F. Du +4 more
2017PLoS ONE4 citations Open access
Semantic Scholar
Nimotuzumab plus paclitaxel and cisplatin as first-line treatment for esophageal squamous cell cancer: A single center prospective clinical trial.
Xiao-Dong Zhang, Ming Lu, Xi-Cheng Wang, Jie Li +11 more
20134 citations
Semantic Scholar
[Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
J. Gong, Xiao-Dong Zhang, Jie Li, Lijun Di +2 more
2007Ai zheng = Aizheng = Chinese journal of cancer4 citations
Semantic Scholar
Integrated bioinformatics analysis to identify key genes related to the prognosis of esophageal squamous cell carcinoma
Ying Yang, Zhi-Wei Sun, You-Wu Shi, Jing Sun +1 more
2021Translational Cancer Research3 citations Open access
Semantic Scholar
Synchronous and metachronous metastasis to renal parenchyma of esophageal squamous cell carcinoma: two case reports and review of the literature
J. Jia, Wei Sun, D. Lin, Xiao-Dong Zhang
2021Translational Cancer Research3 citations Open access
Semantic Scholar
Phase 1 dose-escalation study of apatinib and irinotecan in esophageal squamous cell carcinoma patients
J. Jia, Jing Yu, Zhi-Wei Sun, Ying Yang +3 more
2021Translational Cancer Research3 citations Open access
Semantic Scholar
[Cetuximab in combination with chemotherapy for patients with gastrointestinal cancer].
Xiao-Tian Zhang, Lin Shen, Xiao-Dong Zhang, Jie Li +1 more
2008Zhonghua zhong liu za zhi [Chinese journal of oncology]3 citations
Semantic Scholar
[Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer].
Jian Li, Jian-ming Xu, Jie Li, Xiao-Dong Zhang +6 more
2008Zhonghua zhong liu za zhi [Chinese journal of oncology]3 citations
Semantic Scholar
Abstract 6226: Therapeutic vulnerability of MTAP-deleted nasopharyngeal carcinoma by MAT2A inhibitors
Y. Chan, Chi M. Tsang, G. T. Chung, Ka F. To +4 more
2023Cancer Research2 citations
Semantic Scholar
Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane
Zhi-Wei Sun, Xin Yang, F. Du, You-Wu Shi +7 more
2022Journal of Gene Medicine2 citations Open access
Semantic Scholar
Failure Patterns after Definitive Chemoradiation Therapy with Involved-Field Irradiation for Locally Advanced Esophageal Squamous Cell Carcinoma
Ming-Huan Li, Xiao-Dong Zhang, Z. Liao, Xue Meng +7 more
20142 citations
Semantic Scholar
The assessment of clinicopathological features, therapy pattern and survival benefit of 162 gastric cancers with liver metastases.
Jian Li, Ming Lu, Jie Li, Xiao-Dong Zhang +3 more
2013Hepato-Gastroenterology2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Jia×15
Invite
J. Jia — researcher profile on SciRah
Jie Li×14
Invite
Jie Li — researcher profile on SciRah
Lin Shen×12
Invite
Lin Shen — researcher profile on SciRah
Jing Yu×12
Invite
Jing Yu — researcher profile on SciRah

×11

Invite

Zhi-Wei Sun — researcher profile on SciRah

Invite

Ying Yang — researcher profile on SciRah

Invite

Lin Wu — researcher profile on SciRah

Invite

Yan Li — researcher profile on SciRah

Invite

F. Du — researcher profile on SciRah

Chuan-Ling Liu×7

Invite

Chuan-Ling Liu — researcher profile on SciRah

Invite

Yanjie Xiao — researcher profile on SciRah

Invite

M. Jin — researcher profile on SciRah